Susquehanna International Group
NAGE

Susquehanna International Group’s Niagen Bioscience NAGE Stock Holding History

Susquehanna International Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.8K Sell
15,600
-600
-4% -$3.24K ﹤0.01% 12523
2025
Q4 		$103K Sell
16,200
-18,900
-54% -$131K ﹤0.01% 11438
2025
Q3 		$327K Sell
35,100
-63,500
-64% -$641K ﹤0.01% 9916
2025
Q2 		$1.42M Buy
98,600
+12,700
+15% +$125K ﹤0.01% 6587
2025
Q1 		$593K Sell
85,900
-22,900
-21% -$144K ﹤0.01% 8532
2024
Q4 		$578K Buy
108,800
+81,000
+291% +$443K ﹤0.01% 8309
2024
Q3 		$101K Sell
27,800
-46,000
-62% -$145K ﹤0.01% 11053
2024
Q2 		$201K Buy
73,800
+2,500
+4% +$8.37K ﹤0.01% 10348
2024
Q1 		$248K Buy
+71,300
New +$132K ﹤0.01% 10135
2022
Q1 		– Sell
-16,800
Closed -$63K – 14153
2021
Q4 		$63K Sell
16,800
-165,500
-91% -$894K ﹤0.01% 12437
2021
Q3 		$1.14M Buy
182,300
+26,000
+17% +$214K ﹤0.01% 7224
2021
Q2 		$1.54M Sell
156,300
-86,700
-36% -$756K ﹤0.01% 6560
2021
Q1 		$2.27M Buy
+243,000
New +$1.93M ﹤0.01% 5624
2020
Q2 		– Sell
-27,300
Closed -$89K – 11095
2020
Q1 		$89K Buy
27,300
+10,500
+63% +$40.3K ﹤0.01% 9395
2019
Q4 		$72K Buy
16,800
+3,600
+27% +$12.8K ﹤0.01% 9248
2019
Q3 		$52K Sell
13,200
-9,700
-42% -$41.4K ﹤0.01% 9767
2019
Q2 		$106K Buy
22,900
+3,600
+19% +$15.4K ﹤0.01% 9581
2019
Q1 		$81K Buy
+19,300
New +$69.6K ﹤0.01% 8325
2018
Q3 		– Sell
-54,700
Closed -$203K – 10412
2018
Q2 		$203K Sell
54,700
-31,900
-37% -$121K ﹤0.01% 8590
2018
Q1 		$364K Buy
+86,600
New +$453K ﹤0.01% 7280
2016
Q4 		– Sell
-48,400
Closed -$144K – 10274
2016
Q3 		$144K Sell
48,400
-4,500
-9% -$16.5K ﹤0.01% 7798
2016
Q2 		$219K Buy
+52,900
New +$250K ﹤0.01% 7455

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group's NAGE Position: Q1 2026 in Review

Susquehanna International Group increased its Niagen Bioscience (NAGE) stake by 5% in Q1 2026, buying an estimated $12.5K and bringing the position to 48,672 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11551.

Susquehanna International Group first reported a position in NAGE in Q2 2016 and has held it in 30 quarters since. The position peaked at $3.28M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Susquehanna International Group held 48,672 shares of Niagen Bioscience worth $215K as of Q1 2026.
  • Susquehanna International Group bought 2,307 Niagen Bioscience shares in Q1 2026, an estimated $12.5K.
  • Niagen Bioscience made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11551 holding.
  • Susquehanna International Group first reported a position in Niagen Bioscience in Q2 2016 and has held it in 30 quarters since.
  • Susquehanna International Group's Niagen Bioscience position peaked at $3.28M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.